Skip to content

A study on the medications prescribed to children suffering from cancer for better cancer treatment in the future

Evaluation of prescription pattern of drugs in paediatric cancer patients in a tertiary care hospital: An observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/01/011263
Enrollment
600
Registered
2018-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Paediatric Cancers

Interventions

None listed

Sponsors

Dr Girish Chinnaswamy
Lead Sponsor
Dr Yashashri Shetty
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender and age between 3months -15 years(19) diagnosed with cancer and has received treatment for atleast 6 weeks duration. 2. Legally Acceptable Representative(LAR)of the patient willing to give voluntary informed consent. 3. Patient between the age 7-12 years willing to give voluntary verbal assent. 4.Patient above the age of 12 years willing to give voluntary informed assent.

Exclusion criteria

Exclusion criteria: Any other medical condition, which in the opinion of the investigator precludes the inclusion of the participant.

Design outcomes

Primary

MeasureTime frame
To evaluate the prescription pattern of drugs used in treatment of paediatric cancer patientsTimepoint: February 2018 - December 2019

Secondary

MeasureTime frame
To assess the off-label use of anti-cancer drugs used in paediatric oncology.Off label use will be analyzed using the following information about the anti-cancer drugs prescribed â?? 1.Dose 2.Dosage form 3.Frequency of administration 4.Indication of the drug 5.Route of administration Timepoint: February 2018 - December 2019

Countries

India

Contacts

Public ContactDr Manjesh P S

Seth G S Medical College and KEM Hospital

manjeshps3840@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026